Brian Huntly
Cambridge haematologist and EHA President Elect whose laboratory studies how epigenetic regulators drive leukaemia and how they can be targeted.
Overview
Brian Huntly is President Elect of the European Hematology Association and Professor of Leukaemia Stem Cell Biology at the University of Cambridge. His group investigates the transcriptional and epigenetic mechanisms that initiate and maintain acute myeloid leukaemia. He combines clinical haematology practice with laboratory research on novel leukaemia therapies.
Pages like this
not linked directly; found by shared links- PersonKonstanze Döhner
Shares European Hematology Association, Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
- PersonHubert Serve
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
- PersonThomas Kindler
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
- PersonMartin Bornhäuser
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology, leukaemia.
- PersonTim Somervaille
Shares Acute myeloid leukaemia and the tags clinician-scientist, haematology, leukaemia.
- PersonLars Bullinger
Shares European Hematology Association, Acute myeloid leukaemia.
- PersonNorbert Vey
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
- PersonChristian Brandts
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.